Evaluation of High Dose Methotrexate Toxicity
Condition(s):Methotrexate ToxicityLast Updated:November 8, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Methotrexate ToxicityLast Updated:November 8, 2023Not yet recruiting
Condition(s):Acute Kidney Injury; Drug ToxicityLast Updated:June 12, 2023Recruiting
Condition(s):Localized PsoriasisLast Updated:June 7, 2022Recruiting
Condition(s):Alopecia AreataLast Updated:November 13, 2023Not yet recruiting
Condition(s):Ectopic PregnancyLast Updated:March 8, 2024Not yet recruiting
Condition(s):Rheumatoid ArthritisLast Updated:August 22, 2023Recruiting
Condition(s):Rheumatoid ArthritisLast Updated:March 8, 2024Not yet recruiting
Condition(s):Gestational Trophoblastic Neoplasias (GTN)Last Updated:February 29, 2024Recruiting
Condition(s):Graft Vs Host Disease; Hematopoietic NeoplasmLast Updated:September 14, 2021Recruiting
Condition(s):Rheumatoid Arthritis; Insufficient Response to Methotrexate or LeflunomideLast Updated:July 12, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.